Company Filing History:
1 out of 113 
1 out of 1 Years Active: 2008
Title: The Innovative Contributions of Joel A. Peek in Immunology
Introduction
Joel A. Peek, based in Brentwood, TN, is an innovative inventor recognized for his contributions to the field of immunology. With a focus on enhancing immune responses, he has developed a unique patent that presents exciting possibilities for vaccine adjuvants.
Latest Patents
One of Joel A. Peek's notable patents is titled "Mutant Cholera Holotoxin as an Adjuvant." This invention involves a mutant cholera holotoxin that features a point mutation at amino acid 29 of the A subunit, where the glutamic acid residue is substituted by an amino acid other than aspartic acid, enhancing the immune response in vertebrate hosts to selected antigens from pathogenic organisms. In a specific embodiment of this invention, histidine is used as the amino acid at position 29. The patent also discusses the potential for additional mutations and the incorporation of a second adjuvant, presenting a multifaceted approach to improving immune response in vaccine formulations.
Career Highlights
Joel A. Peek has held significant roles at prominent institutions, including Wyeth Holdings Corporation and the United States of America, as represented by the Uniformed Services University of the Health Sciences. His experience in these organizations has contributed to his development of innovative solutions in the field of health sciences.
Collaborations
Throughout his career, Joel has collaborated with esteemed colleagues such as Randall K. Holmes and Michael G. Jobling. Their collective efforts underscore the importance of teamwork in advancing research and development in immunological applications.
Conclusion
Joel A. Peek is a significant figure in the world of innovation, particularly in immunology. His patent related to mutant cholera holotoxin exemplifies his dedication to enhancing immune responses and provides a foundation for future advancements in vaccine development. His career reflects a commitment to collaboration and innovation, marking him as a noteworthy inventor in the field.